Pharmaceutical sales in 2012 breaking breakthrough.doc

 PAGE \* MERGEFORMAT 8 Pharmaceutical sales in 2012 breaking breakthrough Pharmaceutical industry as the country’s frequent introduction of relevant policies, such as the official website of the Ministry of Science jointly developed ten departments lt;lt;medical technology development, ‘second five’gt;gt; one of its priorities, including to further increase the field of medicine science and technology investment. upcoming medical policy, as well as lt;lt;bio-pharmaceutical industry, ‘second five’gt;gt; and lt;lt;Medical Device Industry and Technology Development Plan 2011-2015gt;gt;, because of these policies, capital market medicine are mostly optimistic about the prospects, but because of the pharmaceutical industry itself is still not eliminate the chronic illness, the individual will not be good national policy to bring the entire pharmaceutical industry are positive, which depends for that part of the business, the absence of competitive SMEs can be worse. The next three years, new medical reform into the deep water area, the pharmaceutical industry growth in the economy diminished, but the benefits will be weaker economy, small and medium pharmaceutical distribution companies will face a more difficult external environment, the rapid increase in industry concentration, a large number of less competitive SMEs will be a merger or acquisition, large-scale enterprise competition will be formed I SHI Li-chen first to sum up China’s pharmaceutical industry market existing chronic illness: 1 product homogeneity still exists, due to the operation of the bidding system, price competition has become the generic drugs or generic key tool. 2, the market concentration is low, the pharmaceutical industry, scattered resources, giant full situation has not yet formed. 3 industry, pharmaceutical industry’s unique characteristics are relatively weak planning, product promotion and brand building means convergence. 4 channels with low efficiency, multi-level cha